Mexico participates in Walvax COVID-19 vaccine trials
Media
Dec 7, 2021
adn40
Trials of the Walvax vaccine against COVID-19 are being carried out in Mexico. The product is based on the mRNA, same as the moderna and pfizer vaccines. It is a biologic developed in China and 6,000 volunteers over 18 years of age are being recruited nationally.
Related Links
Nov 29, 2024
Walvax Strengthens Commitment to African Vaccine Manufacturing at EVMA Inaugural Event
Learn More
Sep 27, 2023
Walvax Participated in the 24th Annual General Meeting of the Developing Countries Vaccine Manufacturers Network (DCVMN) in Cape Town, South Africa
Learn More
May 19, 2023
Walvax’s PCV13-TT Receives Endorsement from the Pediatric Infectious Disease Society of Thailand
Learn More